KUALA LUMPUR: DC Healthcare Holdings Bhd
is committed to continuous growth, with a focus on outlet expansion, including the recently operational branches in Ipoh and Taman Molek, Johor Bahru, according to managing director Dr. Chong Tze Sheng.
“This year has truly been a transformative period for DC Healthcare, underscored by our strategic expansions, the welcoming of esteemed medical advisor Prof Datuk Dr Rohaizat Yon, and the successful opening of our new branches in Taman Molek and Ipoh. While we've navigated through short-term hurdles, our trajectory towards growth in 2024 looks incredibly promising,” Chong said in a statement.
The aesthetic medical services provider posted a a net loss of RM1.07mil and a revenue of RM17.57mil for the fourth quarter ended Dec 31, 2023 (4Q23).
For the full year, it posted a net profit of RM2.56mil on revenue of RM67.8mil.
There are no comparative figures for the preceding quarter and period-to-date available as no interim financial report was prepared for the comparative financial period concerned.
“As we move forward, our focus remains steadfast on setting new standards in aesthetic medicine, inspired by our dedication to excellence, innovation, and the deep-seated trust placed in us by our clients.
“With these solid foundations, DC Healthcare is not just aiming for success in the coming year but setting the stage for a legacy of leadership and excellence in the industry,” Chong said.
